Page last updated: 2024-08-17

physostigmine and Cognitive Decline

physostigmine has been researched along with Cognitive Decline in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Abels, W; Akyüz, L; Borchers, F; Brockhaus, WR; Ely, EW; Fabian, M; Feldheiser, A; Kipping, V; Knaak, C; Kunzmann, K; Menon, DK; Mertens, M; Müller, O; Piper, SK; Pratschke, J; Shadenok, A; Spies, CD; Wernecke, KD; Wiebach, J1
Amaral, JD; Bernardi, J; Brandão, R; Costa, L; da Costa, M; Fiuza, T; Pereira, ME; Ribeiro, MF; Rodrigues, CMP1
Barak, S; Becker, KG; Becker, RE; Fukui, K; Greig, NH; Hoffer, BJ; Holloway, HW; Lehrmann, E; Li, Y; Luo, Y; Perez, E; Pick, CG; Rubovitch, V; Tamargo, IA; Tweedie, D; Van Praag, H; Wood, WH; Yu, QS; Zhang, Y1
Chang, MY; Greig, NH; John, V; Maccecchini, ML; Pan, C; Zetterberg, H1

Trials

2 trial(s) available for physostigmine and Cognitive Decline

ArticleYear
Physostigmine for prevention of postoperative delirium and long-term cognitive dysfunction in liver surgery: A double-blinded randomised controlled trial.
    European journal of anaesthesiology, 2021, 09-01, Volume: 38, Issue:9

    Topics: Adolescent; Adult; Cognitive Dysfunction; Delirium; Humans; Liver; Physostigmine; Postoperative Complications

2021
Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-β peptide and τ levels: target engagement, tolerability and pharmacokinetics in humans.
    Journal of neurology, neurosurgery, and psychiatry, 2012, Volume: 83, Issue:9

    Topics: Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Cognitive Dysfunction; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Inflammation Mediators; Male; Peptide Fragments; Physostigmine; Rats; Rats, Inbred F344; tau Proteins

2012

Other Studies

2 other study(ies) available for physostigmine and Cognitive Decline

ArticleYear
N-acetylcysteine treatment attenuates the cognitive impairment and synaptic plasticity loss induced by streptozotocin.
    Chemico-biological interactions, 2017, Jun-25, Volume: 272

    Topics: Acetylcholinesterase; Acetylcysteine; Animals; Cerebral Cortex; Cognitive Dysfunction; Disease Models, Animal; Hippocampus; Immunohistochemistry; Male; Maze Learning; Mice; Motor Activity; Neuronal Plasticity; Neuroprotective Agents; Oxidative Stress; Physostigmine; Receptor, trkB; Streptozocin; Superoxide Dismutase

2017
Cognitive Impairments Induced by Concussive Mild Traumatic Brain Injury in Mouse Are Ameliorated by Treatment with Phenserine via Multiple Non-Cholinergic and Cholinergic Mechanisms.
    PloS one, 2016, Volume: 11, Issue:6

    Topics: Animals; Brain Concussion; Cholinergic Agents; Cholinesterase Inhibitors; Cognitive Dysfunction; Disease Models, Animal; Gene Expression Regulation; Glutamic Acid; Hippocampus; Humans; Lipid Peroxidation; Maze Learning; Mice; Neurons; Oxidative Stress; Physostigmine

2016